Systems-level conservation of the proximal TCR signaling network of mice and humans

Author:

Nicolas Philippe1ORCID,Ollier Jocelyn23ORCID,Mori Daiki14ORCID,Voisinne Guillaume1ORCID,Celis-Gutierrez Javier14ORCID,Gregoire Claude1ORCID,Perroteau Jeanne1ORCID,Vivien Régine23ORCID,Camus Mylène5ORCID,Burlet-Schiltz Odile5ORCID,Gonzalez de Peredo Anne5ORCID,Clémenceau Béatrice23ORCID,Roncagalli Romain1ORCID,Vié Henri23ORCID,Malissen Bernard14ORCID

Affiliation:

1. Centre d’Immunologie de Marseille-Luminy, Aix Marseille Université, Institut national de la santé et de la recherche médicale, Centre national de la recherche scientifique, Marseille, France 1

2. Centre de Recherche en Cancérologie et Immunologie Nantes Angers, Institut national de la santé et de la recherche médicale, Centre national de la recherche scientifique, Université d'Angers, Université de Nantes, Nantes, France 2

3. LabEx Immunotherapy–Graft–Oncology, Nantes, France 3

4. Centre d’Immunophénomique, Aix Marseille Université, Institut national de la santé et de la recherche médicale, Centre national de la recherche scientifique, Marseille, France 4

5. Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre national de la recherche scientifique Université Paul Sabatier, Toulouse, France 5

Abstract

We exploited traceable gene tagging in primary human T cells to establish the composition and dynamics of seven canonical TCR-induced protein signaling complexes (signalosomes) using affinity purification coupled with mass spectrometry (AP-MS). It unveiled how the LAT adaptor assembles higher-order molecular condensates and revealed that the proximal TCR-signaling network has a high degree of qualitative and quantitative conservation between human CD4+ and CD8+ T cells. Such systems-level conservation also extended across human and mouse T cells and unexpectedly encompassed protein–protein interaction stoichiometry. Independently of evolutionary considerations, our study suggests that a drug targeting the proximal TCR signaling network should behave similarly when applied to human and mouse T cells. However, considering that signaling differences likely exist between the distal TCR-signaling pathway of human and mouse, our fast-track AP-MS approach should be favored to determine the mechanism of action of drugs targeting human T cell activation. An opportunity is illustrated here using an inhibitor of the LCK protein tyrosine kinase as a proof-of-concept.

Funder

Centre National de la Recherche Scientifique

Institut national de la santé et de la recherche médicale

European Research Council

Horizon 2020 Framework Programme

MSDAvenir Fund

DCBIOL

LabEx

Fonds Unique Interministériel

Investissement d’Avenir

Instituts thématiques multiorganismes Aviesan

MSDAvenir

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3